Javascript must be enabled to continue!
Synergistic Effects of Tranylcypromine and NRF2 Inhibitor: A Repurposing Strategy for Effective Cancer Therapy
View through CrossRef
AbstractDrug repurposing has emerged as an attractive strategy for accelerating drug discovery for cancer treatment. In this study, we investigated combining Tranylcypromine (TCP) with a number of well‐characterized drugs. Among these combinations, NRF2 inhibitor (ML385) exhibited synergistic effects in combination with TCP. Specifically, our results showed that the combination of TCP and ML385 resulted in a significant reduction in tumor proliferation while neither drug affected cancer cell growth meaningfully on its own. While further studies are needed to understand fully the extent of the synergistic efficacy, the underlying respective mechanisms and the potential side effects of this approach, our study has yielded a promising start for the development of an effective combination cancer therapy.
Title: Synergistic Effects of Tranylcypromine and NRF2 Inhibitor: A Repurposing Strategy for Effective Cancer Therapy
Description:
AbstractDrug repurposing has emerged as an attractive strategy for accelerating drug discovery for cancer treatment.
In this study, we investigated combining Tranylcypromine (TCP) with a number of well‐characterized drugs.
Among these combinations, NRF2 inhibitor (ML385) exhibited synergistic effects in combination with TCP.
Specifically, our results showed that the combination of TCP and ML385 resulted in a significant reduction in tumor proliferation while neither drug affected cancer cell growth meaningfully on its own.
While further studies are needed to understand fully the extent of the synergistic efficacy, the underlying respective mechanisms and the potential side effects of this approach, our study has yielded a promising start for the development of an effective combination cancer therapy.
Related Results
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
A Stress-Responsive Transcriptional Factor NRF2 Activates Hematopoietic Stem Cells
Abstract
KEAP1-NRF2 system is a major regulator of cellular redox balance and xenobiotic metabolism. NRF2 is an inducible transcription factor, and KEAP1 is its nega...
P–117 Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
P–117 Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
Abstract
Study question
Could Nrf2 polymorphism (–617C>A; rs6721961) and oxidative stress (OS)-induced changes of signatu...
P-117 Pre-selected for an award: Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
P-117 Pre-selected for an award: Bioinformatic analysis of NRF2 in the study of association of NRF2 variant and male infertility related to smoking status
Abstract
Study question
Could Nrf2 polymorphism (-617C>A; rs6721961) and oxidative stress (OS)-induced changes of signatu...
Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication
Oxidative stress sensor Keap1 recognizes HBx protein to activate the Nrf2/ARE signaling pathway, thereby inhibiting hepatitis B virus replication
ABSTRACT
Hepatitis B virus (HBV) infection promotes reactive oxygen species production while paradoxically inducing the expression of antioxidant enzymes. HBV-induced dis...
NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-Deficient Mice
NADPH Oxidase-Dependent Reactive Oxygen Species Mediate Amplified TLR4 Signaling and Sepsis-Induced Mortality in Nrf2-Deficient Mice
Abstract
Sepsis syndrome is characterized by a dysregulated inflammatory response to infection. NADPH oxidase-dependent reactive oxygen species (ROS) play significan...
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Combination of Tranylcypromine and Mirtazapine in Difficult-to-Treat Depression
Abstract
Background
About one third of depression patients do not respond to the first antidepressant trial. Difficult-to-treat depression was su...
Abstract 391: Role of NRF2 in HIF-2α-mediated cancer stem cell phenotype
Abstract 391: Role of NRF2 in HIF-2α-mediated cancer stem cell phenotype
Abstract
The acquisition of cancer stem cell (CSC) properties is influenced by the microenvironment, with tumor hypoxia playing a pivotal role. Elevated levels of nu...
Abstract 1702: Loss of KEAP1 promotes R-loop formation independent of NRF2
Abstract 1702: Loss of KEAP1 promotes R-loop formation independent of NRF2
Abstract
This study investigates the mechanism of R-loop formation as a consequence of KEAP1 depletion. R-loops, described as three-stranded nucleic acid structures ...

